Kiwifruit, cannabis and smartphone apps are among the latest sleep aids in the spotlight at an international sleep conference being held in Sydney today and tomorrow. Sleep DownUnder 2019 will host more than 800 of Australasia’s sleep experts to reveal the latest research into sleep problems like insomnia, obstructive sleep apnea (OSA), jet lag and snoring. Among the discoveries are a raft of …
Read More »
National Carers Week is an opportunity to acknowledge the profoundly positive impact that unpaid carers have on those around them. Every day Australia’s 2.7 million unpaid carers give their time and energy to support the needs of others and significantly strengthen the social fabric of Australia’s communities. Webstercare Managing Director …
Read More »
To commemorate World Sight Day today, Glaucoma Australia has announced the inaugural recipients of its new Glaucoma Research Grants Program. Research grants have been awarded to Dr George Kong from the Royal Victorian Eye and Ear Hospital and Professor Jamie Craig from Flinders University. Since 2006, Glaucoma Australia has facilitated …
Read More »
In an Australian first, eating disorders (ED) represent the first mental health disorder to be assigned specific item numbers under the revised Medicare Benefits Schedule (MBS) scheme from the beginning of November. This development has sparked an urgent call by ED experts to the Australian health workforce to upskill in …
Read More »
Seven finalists have been selected for the 2019 Australian Mental Health Prize. The prize, now in its fourth year, recognises Australians who have made outstanding contributions to the promotion of mental health or the prevention and treatment of mental illness. This year’s winner will be announced at a mental health …
Read More »
In an Australian-first, an immunotherapy, anti-angiogenic and chemotherapy combination will be listed on the Pharmaceutical Benefits Scheme on October 1, 2019 for the treatment of metastatic non-small cell lung cancer (NSCLC). Atezolizumab (sold as Tecentriq) and bevacizumab (sold as Avastin) and a platinum-doublet chemotherapy will be reimbursed for the first-line …
Read More »
The Pharmacy Board of Australia is recognising the role of pharmacists in ensuring the safe use of medicines during this year’s World Pharmacists Day. Marked worldwide on September 25, this year’s theme is ‘Safe and effective medicines for all’ in recognition of the vital role of pharmacists in safeguarding patient …
Read More »
The TerryWhite Chemmart Network Partner conference concluded last night with a special gala dinner held on the Gold Coast and the announcement of the HEART Award winners for 2019. The award covers recognition across health, customer engagement, service and leadership. The most prestigious award of the year – the TerryWhite …
Read More »
IVF success rates in Australia and New Zealand have continued to improve, while the number of IVF twins are falling, a new UNSW report has shown. The ‘Assisted Reproductive Technology in Australia and New Zealand 2017’ report shows the overall live birth rate per embryo transfer has increased from 23.6 per …
Read More »
A novel triplet therapy for newly diagnosed multiple myeloma (NDMM) patients is now Therapeutic Goods Administration (TGA) approved. Revlimid (lenalidomide), in combination with bortezomib and dexamethasone (RVd), is now indicated for the treatment of patients with previously untreated multiple myeloma. The medication is an immunomodulating agent that inhibits the proliferation …
Read More »
Retail Pharmacy A 360° view of pharmacy